BioSpace News Archive

Business

Deep Branch Biotechnology’s Peter Rowe Wants to Save the Planet

Peter Rowe, Deep Branch Biotechnology’s co-founder and Commercial Lead, took time to speak with BioSpace about his company, its progress, and where it’s headed.

May 10, 2019
·
5 min read
·
Mark Terry
Pharm Country

Clinical Catch-up from Last Week: May 5-10

Almost every week, biopharma companies release results from ongoing clinical trials. Here’s a roundup of some of the top clinical trial news from the previous week.

May 10, 2019
·
7 min read
·
Mark Terry
Drug Development

Moderna Publishes Influenza Vaccine Clinical Trial Data

Cambridge, Mass.-based Moderna announced publication of results from two Phase I clinical trials of mRNA vaccines against two strains of influenza, H10N8 and H7N0. They were both published in the journal Vaccine.

May 10, 2019
·
3 min read
·
Mark Terry
FDA

FDA Action Alert: Regeneron, Bristol-Myers Squibb and Incyte

May has been a fairly slow month for approvals by the U.S. Food and Drug Administration (FDA). There are currently only two scheduled for the rest of the month, with a third that has been withdrawn. Let’s take a look.

May 10, 2019
·
3 min read
·
Mark Terry
Business

Forty Seven and AstraZenca Team up on NHL Triple-Combination Therapy

The triple combination therapy does not use a chemotherapy agent in its experimental treatment for an aggressive blood cancer.

May 10, 2019
·
2 min read
·
Alex Keown
Job Trends

Bayer to Invest $150 Million in New Cell Manufacturing Plant in Berkeley

Bayer plans to build a Cell Culture Technology Center in Berkeley, Calif., investing $150 million in the project. The center will focus on developing biologics, an area where Bayer lags behind its competitors.

May 10, 2019
·
2 min read
·
Mark Terry
Policy

Gilead Pledges 2.4 Million Annual Dose Donations of Drug to End HIV in the U.S.

The company is pledging to support a goal to end HIV in the U.S. by 2030 announced by the president during the State of the Union this year.

May 10, 2019
·
3 min read
·
Alex Keown
Policy

J&J Takes Hits on Talc Lawsuit, Settles Xarelto Suit, Faces Pricing Criticism

Johnson & Johnson has lost several major lawsuits over allegations that asbestos in its talcum powder contributes to ovarian cancer.

May 10, 2019
·
3 min read
·
Mark Terry
Business

SEC Rule Change Will Ease Audit Requirements for Smaller Companies

Companies that generate revenue less than $100 million would not have to undergo regular outside audits.

May 10, 2019
·
2 min read
·
Alex Keown
Deals

QIAGEN: Disclosure according to Article 5 Section (1) and (6) of the EU Regulation 596/2014 and Article 2 Section (1) of the Delegated EU Regulation 2016/1052/ Share Repurchase - May 10, 2019

QIAGEN N.V. announces that it will initiate the repurchase of a fourth tranche of shares under the share repurchase program which was announced by an ad hoc announcement dated January 31, 2018.

May 10, 2019
·
1 min read